115 related articles for article (PubMed ID: 3273332)
1. [Antithrombin III and heparinemia in patients on hemodialysis].
Nagami AE; Sesin AM; Nattero GN
Rev Fac Cien Med Univ Nac Cordoba; 1988; 46(1):23-6. PubMed ID: 3273332
[No Abstract] [Full Text] [Related]
2. Plasma antithrombin III concentration in patients on regular haemodialysis treatment.
Jørgensen M; Eriksen HO; Tranebjaerg L
Nephron; 1985; 40(1):22-4. PubMed ID: 4000333
[TBL] [Abstract][Full Text] [Related]
3. [Antithrombin III in chronic renal insufficiency].
Bekić-Kaluza S; Macanović M
Med Arh; 1991; 45(1-2):3-8. PubMed ID: 1366314
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin III in uremia.
Jørgensen KA; Stoffersen E
Scand J Urol Nephrol; 1979; 13(3):299-303. PubMed ID: 531528
[TBL] [Abstract][Full Text] [Related]
5. [Effect of exogenous heparin on heparinemia and coagulation in coronary arteriosclerosis].
Szigeti I; Kótay-Lákatos E; Vertán MZ; Kiss R
Med Interna (Bucur); 1967 May; 19(5):549-52. PubMed ID: 6077944
[No Abstract] [Full Text] [Related]
6. Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurements.
Fareed J; Messmore HL; Walenga JM; Bermes EW; Bick RL
Semin Thromb Hemost; 1982 Oct; 8(4):288-301. PubMed ID: 6817417
[No Abstract] [Full Text] [Related]
7. [Effect of heparin on desmofibrin-generating activity of the blood in patients with chronic kidney failure treated with hemodialysis].
Zuch A; Chmielewska J; Poplawski A
Pol Arch Med Wewn; 1977 Oct; 58(4):367-75. PubMed ID: 928176
[No Abstract] [Full Text] [Related]
8. [Antithrombin III activity during hemodialysis].
Rydzewski A; Soszka J; Myśliwiec M
Pol Arch Med Wewn; 1983 Feb; 69(2):123-8. PubMed ID: 6889150
[No Abstract] [Full Text] [Related]
9. [Acute effects of sulodexide on the lipid profile and on antithrombin III in patients with chronic renal insufficiency in hemodialysis treatment].
Averna MR; Citarella P; Picone F; Capodicasa G; Galione A; Rini G; Notarbartolo A
Clin Ter; 1984 Jan; 108(2):111-4. PubMed ID: 6232045
[No Abstract] [Full Text] [Related]
10. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
Ireland HA; Boisclair MD; Lane DA; Thompson E; Curtis JR
Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
[TBL] [Abstract][Full Text] [Related]
11. [Effect of heparin in uremic patients during hemodialysis].
Cullmann W; Glöckner WM; Müller N
Fortschr Med; 1981 Mar; 99(12):410-2. PubMed ID: 7227936
[TBL] [Abstract][Full Text] [Related]
12. Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.
Raja R; Kramer M; Rosenbaum JL; Bolisay C; Krug M
Proc Clin Dial Transplant Forum; 1980; 10():39-42. PubMed ID: 7346852
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis.
Toulon P; Jacquot C; Capron L; Frydman MO; Vignon D; Aiach M
Thromb Haemost; 1987 Jun; 57(3):263-8. PubMed ID: 3660328
[TBL] [Abstract][Full Text] [Related]
14. [The determination of heparin].
Aiach M
Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
[No Abstract] [Full Text] [Related]
15. [The resistance of activated partial thromboplastin time to heparin infusion during hemodialysis].
Camici M; Sagripanti A; Barsotti G; Baicchi U; Evangelisti L; Morelli E; Giovannetti S
Minerva Med; 1995 Sep; 86(9):353-5. PubMed ID: 7501225
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of erythropoietin treatment on the coagulation system during standardized hemodialysis.
Clyne N; Lins LE; Egberg N
Clin Nephrol; 1995 Apr; 43(4):260-7. PubMed ID: 7606881
[TBL] [Abstract][Full Text] [Related]
17. Effects of hemodialysis and peritoneal dialysis on antithrombin III and platelets.
Woo KT; Wei SS; Lee EJ; Lau YK; Lim CH
Nephron; 1985; 40(1):25-8. PubMed ID: 4000334
[TBL] [Abstract][Full Text] [Related]
18. Hemodialysis with defibrotide: effects on coagulation parameters.
Filimberti E; Cinotti S; Salvadori M; Amato M; Longo G; Nazzari M; Morfini M
Int J Artif Organs; 1992 Oct; 15(10):590-4. PubMed ID: 1428206
[TBL] [Abstract][Full Text] [Related]
19. [Use of activated coagulation time for evaluation of the degree of heparinization and calculation of heparin pharmacokinetic parameters during hemodialysis].
Khodas MIa; Piatnitskaia GKh; Lanskaia IM; Maksimenko VA; Savina ME
Urol Nefrol (Mosk); 1988; (3):42-8. PubMed ID: 3218006
[No Abstract] [Full Text] [Related]
20. [Individual dosage schedule of heparin therapy in chronic hemodialysis by analytic studies of blood coagulation].
Gläser V; Anstadt M
Z Urol Nephrol; 1990 Mar; 83(3):133-40. PubMed ID: 2356667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
